(Q48382289)

11 February 2018

title

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine. (English)

1 reference

11 February 2018

1 reference

Engber TM

1

1 reference

11 February 2018

Dennis SA

2

1 reference

11 February 2018

Jones BE

3

1 reference

11 February 2018

Miller MS

4

1 reference

11 February 2018

Contreras PC

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

11 February 2018

published in

Neuroscience

1 reference

11 February 2018

volume

87

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

905-911

1 reference

11 February 2018

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Effects of modafinil on symptomatology of human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

A dopamine-sensitive striatal efferent system mapped with [14C]deoxyglucose in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Selective activation of deep layer (V-VI) retrohippocampal cortical neurons during hippocampal sharp waves in the behaving rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Electroencephalographic effects of modafinil, an alpha-1-adrenergic psychostimulant, on the sleep of rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Modafinil binds to the dopamine uptake carrier site with low affinity.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

In defence of optical density ratios in 2-deoxyglucose autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

The relationship of local cerebral glucose utilization to optical density ratios.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Ascending projections of the posterior nucleus of the hypothalamus: PHA-L analysis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

Effects of d- and l-amphetamine on local cerebral glucose utilization in the conscious rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900015-3

7 January 2021

10.1016/S0306-4522(98)00015-3

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9759978

1 reference

11 February 2018